Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns

Haisco Pharmaceutical licenses inflammatory disease drug to Sentivera: The Chinese biotech is granting ex-China rights for the unnamed candidate to US startup Sentivera, which was founded by ARCH Venture Partners and Population ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 26 August →